This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rappa, L. R. Articles by Simon, W. A. Search for Related Content Social Bookmarking                         What's this?

Desperately Seeking Serendipity: The Past, Present, and Future of Antidepressant Therapy

Florida A&M University, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Miami Campus–Jackson Medical Towers, 1500 NW 12th Ave, Suite 1126, Miami, FL 33136; Memorial Regional Hospital, Department of Psychiatry, 3501 Johnson Street, Hollywood, FL 33021.

Margareth Larose-Pierre

Miami Division, Florida A&M University.

Evans Branch, III

Antonio J. Iglesias

Daryl A. Norwood

Wayne A. Simon

Florida A&M University, College of Pharmacy, Florida A&M University, Miami Campus.

Looking back into the "dark ages" of medicine, we can see a fast evolving armamentarium of medications to treat various illnesses, including those afflicting the brain. Up until the past hundred years or so, there has been little in the way of appropriate psychiatric medication therapy. With the discovery of stimulants and opiates, a new door opened into the science of psychopharmaceuticals. Fifty years ago, the greatest leap in psychiatric medicine occurred serendipitously in the form of antipsychotics and antidepressants, some of which we still use today. The learning curve from then has been on a logarithmic scale, and we are quickly approaching the pinnacle of the curve. However, human nature has yet to catch up to scientific progress, as the stigma of mental illness is often reflected in cultural biases and nonparity with insurance benefits for medical care. Because of today’s diminishing medical and psychiatric health care benefits, we strive for superior and quicker acting drugs for these costly illnesses. The best discoveries lay ahead in the 21st century as the potential of Substance P antagonists, antiglucocorticoids, and N-methyl-D-aspartate receptor antagonists (to name a few) are explored for their benefit in depression. Until then, we strive to understand the inner workings of the human mind to heal those with psychiatric illnesses.

Key Words: history • Substance P • antiglucocorticoids • antidepressants • depression

Journal of Pharmacy Practice, Vol. 14, No. 6, 560-569 (2001)
DOI: 10.1177/089719001129040900


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?